Form Type:  8-K
Filing Date:  3/8/2013 
CIK:  0001235007 
Address:  3000 KENT AVE STE A1-100 
City, State, Zip:  WEST LAFAYETTE, Indiana 47906 
Telephone:  (765) 463-7175 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
-0.25 (-1.31%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
Description of Business
We are a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. We use our proprietary technology to create novel small molecule drug conjugates, or SMDCs, and companion imaging agents. Our SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone. We are also developing companion imaging agents for each of our SMDCs that are designed to identify the patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
      Item 5.02 Departure of Directors or Certain Officers; ...